Product NDC: | 62856-350 |
Proprietary Name: | LUSEDRA |
Non Proprietary Name: | fospropofol disodium |
Active Ingredient(s): | 35 mg/mL & nbsp; fospropofol disodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-350 |
Labeler Name: | Eisai, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022244 |
Marketing Category: | NDA |
Start Marketing Date: | 20081212 |
Package NDC: | 62856-350-58 |
Package Description: | 8 VIAL in 1 TRAY (62856-350-58) > 30 mL in 1 VIAL |
NDC Code | 62856-350-58 |
Proprietary Name | LUSEDRA |
Package Description | 8 VIAL in 1 TRAY (62856-350-58) > 30 mL in 1 VIAL |
Product NDC | 62856-350 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fospropofol disodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20081212 |
Marketing Category Name | NDA |
Labeler Name | Eisai, Inc |
Substance Name | FOSPROPOFOL DISODIUM |
Strength Number | 35 |
Strength Unit | mg/mL |
Pharmaceutical Classes |